Physician profile
Sumathi Puttu
NPI 1649470717
$6,654.18
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,495 · 2020: $2,177 · 2021: $1,593 · 2022: $366 · 2024: $23.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,056.42 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $982.01 | 2019-2022 | |
| Astellas Pharma US INC | $651.97 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $644.43 | 2019-2022 | |
| Lilly USA, LLC | $471.29 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $449.38 | 2019-2022 | |
| Amarin Pharma, INC. | $425.70 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $400.52 | 2019-2021 | |
| Allergan, INC. | $276.60 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $196.62 | 2020-2022 | |
| Opko Pharmaceuticals, LLC | $184.14 | 2020-2022 | |
| Avanir Pharmaceuticals, INC. | $89.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $87.47 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.88 | 2019 | |
| Abbvie INC. | $71.67 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $57.45 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $54.28 | 2019 | |
| Pfizer INC. | $47.87 | 2019-2021 | |
| Mylan Specialty L.P. | $43.67 | 2019 | |
| Esperion Therapeutics, INC. | $41.84 | 2020-2021 | |
| Glaxosmithkline, LLC. | $41.28 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $39.56 | 2021 | |
| Grifols USA, LLC | $35.03 | 2021 | |
| Hologic Sales and Service, LLC | $32.40 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.33 | 2020 | |
| Arbor Pharmaceuticals, INC. | $27.45 | 2019-2020 | |
| Exact Sciences Corporation | $23.41 | 2024 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $22.41 | 2020 | |
| Dexcom, INC. | $21.89 | 2021 | |
| Genentech USA, INC. | $19.78 | 2020 | |
| Abbott Laboratories | $16.11 | 2022 | |
| Hikma Pharmaceuticals USA | $13.86 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.14 | 2020 | |
| Eisai INC. | $12.77 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumathi Puttu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.